(FRTD) as the company works towards acquiring non-dilutive financing. In which will then lead to the building of a manufacturing facility to mass produce the company’s licensed and FDA approved Comprehensive Airway Management System; investors should consider making an investment in this stock. The reason being, over the last several weeks we have seen the accumulation of around 25 million shares of FRTD stock ranging in price 008 to 014. It appears that the company has attracted believers.
The market place for the company’s product is ever expanding and is not limited to the USA alone!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.